ganciclovir (Amici Pharmaceuticals LLC)
Welcome to the PulseAid listing for the ganciclovir drug offered from Amici Pharmaceuticals LLC. This Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Amici Pharmaceuticals LLC |
| NON-PROPRIETARY NAME: | ganciclovir |
| SUBSTANCE NAME: | GANCICLOVIR |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |
| ROUTE: | OPHTHALMIC |
| DOSAGE FORM: | GEL |
| MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
| START MARKETING DATE: | 2017-09-08 |
| END MARKETING DATE: | 0000-00-00 |
ganciclovir HUMAN PRESCRIPTION DRUG Details:
| Item Description | ganciclovir from Amici Pharmaceuticals LLC |
| LABELER NAME: | Amici Pharmaceuticals LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1.5(mg/g) |
| START MARKETING DATE: | 2017-09-08 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69292-015_07e9f59a-60e8-4f3e-a15c-300d330bd2a6 |
| PRODUCT NDC: | 69292-015 |
| APPLICATION NUMBER: | NDA022211 |
Other GANCICLOVIR Pharmaceutical Manufacturers / Labelers:
